Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/25 21:10 | 5/2/25 | EWTX | Health | Drug | Pharmaceutical Preparations | Russell Alan J | CO | DO | Chief Sc | 6 | S.dm | -5,196 | 27.70 | 0 | -188 | 19 | D | |||||||||||||||
5/7/25 21:10 | 5/2/25 | EWTX | Health | Drug | Pharmaceutical Preparations | Moore John R | CO | O | GC | 4 | S.dm | -2,662 | 25.44 | 0 | -105 | 7 | D | |||||||||||||||
5/7/25 21:10 | 5/2/25 | EWTX | Health | Drug | Pharmaceutical Preparations | Koch Kevin | CO | DO | P,CEO | 4 | S.dm | -420 | 24.63 | 0 | -17 | 386 | D | |||||||||||||||
5/7/25 21:09 | 5/2/25 | EWTX | Health | Drug | Pharmaceutical Preparations | Donovan Joanne M. | CO | O | CMO | 4 | S.d | -1,048 | 25.55 | 0 | -41 | 22 | D | |||||||||||||||
5/7/25 21:09 | 5/2/25 | EWTX | Health | Drug | Pharmaceutical Preparations | Derakhshan Behrad | CO | O | Chief Bu | 5 | S.dm | -1,782 | 27.22 | 0 | -65 | 20 | D | |||||||||||||||
5/7/25 21:08 | 5/2/25 | EWTX | Health | Drug | Pharmaceutical Preparations | Carruthers R Michael | CO | O | CFO | 3 | S.d | -3,636 | 28.28 | 0 | -129 | 81 | D | |||||||||||||||
12/27/24 16:30 | 12/24/24 | EWTX | Health | Drug | Pharmaceutical Preparations | Semigran Marc | CO | O | Chief De | 1 | S.d | -882 | 29.69 | 0 | -30 | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |